Using Early Economic Models in Developing your Evidence Strategy
Victoria Paly, Senior Health Economist, ICON Commercialisation & Outcomes
About this talk
The demand from regulators and payers for health economic models is increasing, as these key decision makers struggle to manage budget constraints and provide access to new therapies.
Health economic models are required to demonstrate product value and support reimbursement submissions; however, early economic models can also be used to inform clinical development decisions, develop HEOR and real world evidence (RWE) generation planning and support early pricing and market access discussions.
Join us to learn best practices for developing early economic models to inform key strategic decisions. Through discussion and a case study, get insights on:
- Types of early economic models and why are they important
- Guidelines on their development and the selection of data sources
- Case-examples of use in evidence strategy generation
- How early economic models are used to identify evidence gaps
Speakers: Victoria Paly, Senior Health Economist, ICON Commercialisation & Outcomes & Dhvani Shah, Lead Health Economist, ICON Commercialisation and Outcomes
BioPharma companies and Medical Devices manufacturers face growing operational, regulatory and economic challenges when it comes to developing their drug or device. ICON provides analysis and key insights on these challenges, with practical advice and recommendations.…